Himori N, Ishimori T, Shiratsuchi K, Tsuneda K, Izumi A
Naunyn Schmiedebergs Arch Pharmacol. 1984 Apr;325(4):314-9. doi: 10.1007/BF00504375.
The present experiments were designed to elucidate what mechanism(s) would be responsible for beta-adrenoceptor blocking drugs (beta-blockers)-induced pressor responses in rats. In urethane-anaesthetized rats, 6 beta-blockers at i.v. doses ranging from 0.3 to 300 micrograms/kg evoked the pressor response in a dose-dependent manner. The relative potency in causing the pressor action was correlated not to their beta 1-blocking activities (r = 0.374, P greater than 0.05) but to their beta 2-blocking ones (r = 0.856, P less than 0.05). In pithed or adrenalectomized rats with low levels of plasma catecholamines, however, propranolol failed to exert its sustained pressor action. Propranolol (300 micrograms/kg i.v.) distinctly potentiated the pressor responses not to noradrenaline but to adrenaline and to electrical stimulation of the sympathetic outflow (E.S.) in pithed rats. On the contrary, there was not any potentiation of pressor response to E.S. in pithed, adrenalectomized rats treated with propranolol (300 micrograms/kg i.v.). In rats treated with phenoxybenzamine (5 mg/kg i.v.), adrenaline was shown to have much more potent vasodilating action resulting from beta 2-stimulation than noradrenaline, the dose difference for causing the diastolic blood pressure decrease by a 25 mm Hg being almost 80 times. In pithed rats, infusion of adrenaline at the rate of 0.02 micrograms/min caused a significant increase in plasma adrenaline level from 0.02 +/- 0.01 to 0.45 +/- 0.048 ng/ml, being close to basal level obtained in urethane-anaesthetized rats. Under this situation, propranolol (1-100 micrograms/kg i.v.) showed a distinct pressor response in a dose-dependent fashion as observed in adrenal intact rats anaesthetized with urethane.(ABSTRACT TRUNCATED AT 250 WORDS)
本实验旨在阐明何种机制导致β-肾上腺素能受体阻断药(β-受体阻滞剂)引起大鼠的升压反应。在乌拉坦麻醉的大鼠中,静脉注射剂量为0.3至300微克/千克的6种β-受体阻滞剂以剂量依赖方式诱发升压反应。引起升压作用的相对效价与其β1阻断活性无关(r = 0.374,P>0.05),而与其β2阻断活性相关(r = 0.856,P<0.05)。然而,在血浆儿茶酚胺水平较低的脊髓横断或肾上腺切除的大鼠中,普萘洛尔未能发挥其持续的升压作用。静脉注射300微克/千克的普萘洛尔显著增强了脊髓横断大鼠对肾上腺素而非去甲肾上腺素以及对交感神经传出电刺激(E.S.)的升压反应。相反,在静脉注射300微克/千克普萘洛尔处理的脊髓横断、肾上腺切除的大鼠中,对E.S.的升压反应未出现任何增强。在用酚苄明(静脉注射5毫克/千克)处理的大鼠中,肾上腺素因β2刺激而产生的血管舒张作用比去甲肾上腺素强得多,使舒张压降低25毫米汞柱的剂量差异几乎为80倍。在脊髓横断大鼠中,以0.02微克/分钟的速率输注肾上腺素导致血浆肾上腺素水平从0.02±0.01显著升高至0.45±0.048纳克/毫升,接近乌拉坦麻醉大鼠获得的基础水平。在这种情况下,静脉注射1至100微克/千克的普萘洛尔呈现出与乌拉坦麻醉的完整肾上腺大鼠中观察到的相似的剂量依赖性明显升压反应。(摘要截断于250字)